)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Voyager Therapeutics
Voyager Therapeutics (VYGR) investor relations material
Voyager Therapeutics Oppenheimer 36th Annual Healthcare Life Sciences Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Oppenheimer 36th Annual Healthcare Life Sciences Conference summary26 Feb, 2026
Strategic pillars and financial position
Focused on three pillars: tau-targeting therapies, gene therapy assets entering the clinic, and the NeuroShuttle platform for brain drug delivery.
Two gene therapy programs, including a partnered Neurocrine asset and a wholly owned program, are set to enter clinical trials this year.
NeuroShuttle platform aims to deliver diverse drugs into the brain using novel receptor-based shuttles.
Well-capitalized with cash runway into 2028.
Tau-targeting programs and industry context
Tau is a validated target in Alzheimer's, with its spread correlating more closely with clinical decline than amyloid.
Recent trials (e.g., UCB's bepranemab) showed mixed results, highlighting the importance of epitope selection for antibody efficacy.
VY7523, an anti-tau antibody, completed SAD and MAD enrollment, showing favorable safety and pharmacokinetics.
MAD study is powered to detect effects on tau PET imaging, the primary biomarker for efficacy.
Plans to seek a partner for Phase 3 and possibly Phase 2 due to the scale of Alzheimer's trials.
Gene therapy and tau silencing advancements
VY1706 gene therapy targets 50–70% tau knockdown at low doses, with improved safety by reducing liver exposure.
IND filing for VY1706 expected in Q2, with first patient dosing in H2 this year.
VY1706 offers broad CNS distribution via IV, unlike intrathecal antisense approaches, and will use tau PET imaging as a key endpoint.
BIIB080’s strong clinical and biomarker effects set a benchmark for tau silencing therapies.
J&J ADPD data: What's the VY7523 read-across
VY-1706 vs BIIB080: Key differentiation points
ALPL NeuroShuttle: Differentiating features vs TFR
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Voyager Therapeutics earnings date
Q4 20256 Mar, 2026
Voyager Therapeutics
Next Voyager Therapeutics earnings date
Q4 20256 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Voyager Therapeutics Inc. is a biotechnology company focused on developing gene therapies for the treatment of severe neurological diseases. The company leverages its proprietary platform to create therapies designed to deliver genetic material directly to targeted cells in the brain and other parts of the nervous system. Voyager's research and development efforts focus on treating conditions such as Parkinson’s disease, Huntington’s disease, and other central nervous system disorders. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage